Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page
- CheckyesterdayChange DetectedAdded 'Revision: v3.5.5' and removed 'Revision: v3.5.4' text on the page. This indicates a new revision label for the document/versioning metadata.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedNew trial sites were added across multiple countries (including the US, Argentina, Hungary, Japan, the UK, Poland, Russia, South Korea, and others) and several existing sites were removed, reflecting a revised geographic footprint for NCT03765918. This update changes where participants can enroll and where data collection will occur.SummaryDifference0.6%

- Check44 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a software/version rollout rather than a change to the clinical trial record.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded a Results and Publications section with the NEJM publication and associated outcomes.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision label updated to v3.5.0 (previously v3.4.3).SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.